BoNT/A in the Urinary Bladder—More to the Story than Silencing of Cholinergic Nerves

Botulinum neurotoxin (BoNT/A) is an FDA and NICE approved second-line treatment for overactive bladder (OAB) in patients either not responsive or intolerant to anti-cholinergic drugs. BoNT/A acts to weaken muscle contraction by blocking release of the neurotransmitter acetyl choline (ACh) at neuromu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Hodan, Maignel, Jacquie, Hornby, Fraser, Daly, Donna, Beard, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780360/
https://www.ncbi.nlm.nih.gov/pubmed/35051030
http://dx.doi.org/10.3390/toxins14010053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780360/
https://www.ncbi.nlm.nih.gov/pubmed/35051030
http://dx.doi.org/10.3390/toxins14010053

Ejemplares similares